Real-time reverse transcriptase PCR (rRT-PCR
The pandemic influenza A/H1N1 2009 virus, which was first identified in Mexico and the United States in April 2009 (5, 9) , has rampaged globally for the past year. Although the World Health Organization (WHO) has declared that pandemic influenza A/H1N1 2009 virus is entering the postpandemic period (http://www.who.int/mediacentre/news/statements/2010 /h1n1_vpc_20100810/en/index.html), its future pattern remains to be determined. The pandemic influenza A/H1N1 2009 virus has been predicted to be the predominant influenza A virus causing seasonal influenza in winter/spring 2010-2011 (http: //www.cdc.gov/h1n1flu/qa.htm; http://www.ecdc.europa.eu/en /healthtopics/H1N1/Documents/1003_RA_forward_look_influenza .pdf). In addition, the recent identification of the re-sorting of this virus in pigs poses further, unknown risks to humans (25) . Thus, detection, control, and prevention of an epidemic caused by pandemic influenza A/H1N1 2009 virus is still a global challenge, and an optimized detection method is needed in preparation for another possible outbreak.
Numerous assays for pandemic influenza A/H1N1 2009 virus have been reported, including virus isolation, enzyme-linked immunosorbent assay (ELISA), immunofluorescence analysis, and several kinds of molecular tests, such as conventional reverse transcriptase PCR (cRT-PCR), real-time reverse transcriptase PCR (rRT-PCR), and sequence analysis (1, 3, 4, 11, 17, 18, 20, 22, 26) . Among these, rRT-PCR has been widely used in various clinical and public health laboratories because of its unique advantages, including ease of performance, great accuracy, high sensitivity and specificity, fast turnaround time, high throughput capacity, and minimal carryover contamination (2, 23) . In April 2009, the WHO released the Centers for Disease Control and Prevention (U.S. CDC) rRT-PCR protocol for the detection of pandemic influenza A/H1N1 2009 virus (http://www.who.int/csr/resources/publications/swineflu /CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf). This protocol has been widely used as the diagnostic standard in many countries and as the referee method in multiple studies (6, 14, 18, 24, 27) . Based on this, many rRT-PCR assays have been reported (2, 7, 11, 15, 18, 24, 27, (31) (32) (33) . These assays used different primer and TaqMan probe sets to detect the hemagglutinin (HA) and/or the neuraminidase (NA) gene of pandemic influenza A/H1N1 2009 virus. As the primer-probe design plays a pivotal role in an rRT-PCR assay and the parameters of different primer-probe sets may differ (28, 30) , careful evaluation of the sensitivities, specificities, and performances of different rRT-PCR primer-probe sets will help to improve the rRT-PCR assays for detection of pandemic influenza A/H1N1 2009 virus.
In this study, we used the SW (CDC) primer-probe set (SW H1 Forward, SW H1 Reverse, and SW H1 Probe in the U.S. CDC protocol) from the U.S. CDC's rRT-PCR protocol (http: //www.who.int/csr/resources/publications/swineflu/CDCRealtime (29) . Influenza virus HA/NA, including those of pandemic influenza A/H1N1 2009 virus, were subtyped using multiplex rRT-PCR assays as described previously (33) . The PCR results were confirmed by sequencing. The 50 specimens included 15 positive for an H3N2 subtype, 16 positive for a seasonal H1N1 subtype, 2 positive for enterovirus, 2 positive for rhinovirus, 2 positive for parainfluenza virus, and 13 negative for the respiratory viruses we tested for as described above.
Viral RNA extraction. Viral RNA was extracted from clinical specimens or cultured viruses using the NucliSens easyMag apparatus (bioMérieux, Marcy L'Etoile, France) according to the manufacturer's protocol. The viral nucleic acids were stored at Ϫ80°C prior to use. Table 1 . The thermocycling parameters for these primer-probe sets were based on original reports (7, 11, 18, 24, 27, (31) (32) (33) . However, the number of PCR cycles was set at 45, which was the highest cycle number used in the 12 evaluated assays ( Table  1) . We used the SW (CDC) primer-probe set from the U.S. CDC's rRT-PCR protocol to target the HA gene of pandemic influenza A/H1N1 2009 virus as a referee method. The thermocycling parameters for SW (CDC) were set according to the U.S. CDC's rRT-PCR protocol (http://www.who.int/csr/resources/publications /swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf). For the sake of data analysis, all assays were performed using the same apparatus, a LightCycler 480 instrument (Roche Diagnostics, Mannheim, Germany), and the same one-step RT-PCR kit, the SuperScript III One-Step RT-PCR System with Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA). For all tests, 2 l of nucleic acid solution was added to 23 l of master mixture containing the following components at the indicated final concentrations: 1ϫ reaction buffer, 1 l of SuperScript III RT/Platinum Taq Mix, 500 nM each primer, and 300 nM probe labeled at the 5Ј end with a reporter dye, 6-carboxyfluorescein (FAM), and at the 3Ј end with a nonfluorescent quencher, BHQ-1. Reverse transcription was performed for 30 min at 50°C and for 3 min at 95°C according to the manufacturer's instructions. The baseline fluorescence threshold for each analysis was manually adjusted based on the background fluorescence of the "no-template" control reaction using the baseline subtracted curve fit analysis mode in LightCycler 480 Software 1.5.0. For each analysis, a sample amplification curve exceeding baseline fluorescence with a corresponding cycle threshold (C T ) value (not exceeding 36 in a 45-cycle run) was considered positive. In addition, a C T value between 36 and 45 was considered weakly positive. An amplification curve lower than the baseline fluorescence was defined as negative.
In silico coverage of the primer-probe sets. A total of 1,848 HA and 1,374 NA gene sequences of pandemic influenza A/H1N1 2009 virus were obtained from the Influenza Virus Resource (http://www.ncbi.nlm.nih.gov/genomes/FLU/) for in silico coverage analysis. In silico coverage of primer-probes was calculated using an in-house program, as previously described (33) . A sequence was defined as a "hit" if there were two or fewer substitutions within the probe or if there were no substitutions within 5 bases from the 3Ј end, one or fewer substitution within 10 bases from the 3Ј end, or 3 or fewer substitutions within the primers (16). For degenerate primers or probes, an acceptable "hit" was defined by the presence of an accurate match between the sequence data consensus (made by BioEDIT 7.01 software) and its primers or probes.
Sensitivity (8) . Copies of RNA extracts of the three known subtypes of influenza A virus strains and the other aforementioned viruses were quantified by SYBR green rRT-PCR (10, 33) . The quantifications were done using standard curves made by serial dilutions of plasmids containing partial genes of influenza A and B virus NP, coronavirus RNA polymerase, and adenovirus hexon (data not shown). The limit of detection (LOD) and reproducibility analysis were determined using 10-fold serial dilutions (10 7 to 1 copies/ reaction or 4.0 to 4.0 ϫ 10 Ϫ7 TCID 50 /reaction) of the quantified viral RNA extract of pandemic influenza A/H1N1 2009 virus. Stringent criteria for the LOD were adopted to evaluate the rRT-PCR assays: (i) to achieve the maximum C T values, (ii) to positively detect all three parallel wells (amplification curves exceeding the baseline fluorescence in a 45-cycle run), and (iii) to keep the coefficient of variation (CV) of the C T values less than 10%. Viral RNA extracts were tested at high concentration and high TCID 50 (Table 2) to determine the analytical specificity of the rRT-PCR assays. To further evaluate the specificities of different rRT-PCR assays in clinical testing, we used an additional 50 clinical nasopharyngeal-swab specimens, obtained from PUMCH as described above, for the cross-reaction assay ( Table 3 ). All of the analytical assays were performed at least three times.
Statistical analysis. Statistical analysis for the rRT-PCR assays was performed using McNemar's chi-square test for matched pairs. A P value of Յ0.05 was considered significant.
RESULTS
In silico coverage of the primer-probe sets in this study. To evaluate the coverage of the 12 primer-probe sets derived from the published work for pandemic influenza A/H1N1 2009 virus strains, an in silico analysis was performed using an in-house program. The results showed that the coverage of these primerprobe sets ranged from 98.4% to 100% ( Table 1 ), suggesting that all 12 primer-probe sets target the conserved regions of the HA or NA gene of pandemic influenza A/H1N1 2009 virus.
Specificities of rRT-PCR assays. To assess the specificities of the rRT-PCR assays, all of the sequences of the primerprobe sets were analyzed by BLAST analysis. The actual crossreactivity of the primer-probe sets was examined using a panel of virus strains and clinical specimens (Tables 2 and 3) . Based on BLAST analysis, the SW (j) and SW (c) primer-probe sets, which target the HA gene of pandemic influenza A/H1N1 2009 virus, cross-react with the HA genes of swine H1N2 (such as the A/swine/Hainan/1/2005 strain) (Fig. 1A) and seasonal H1N1 (such as A/Puerto Rico/8/1934) (Fig. 1B) , respectively. The other 10 primer-probe sets tested do not share obvious sequence homology, nor do they cross-react with other respiratory viruses (data not shown Table 2 ). The SW (j) set was not tested against the swine H1N2 subtype because the strain was unavailable. In addition, there were several other nonspecific, weakly positive reactions, such as SW (c) to Ad35 and SW (d) to influenza B virus and OC43 (Table 2) (Tables 3 and 5 ). In addition, SW (g) reacted weakly with parainfluenza virus (1/2) and one negative specimen (Table 3) .
Based on the clinical-sample testing results (Tables 3 and 5 ) and the specificity and sensitivity analyses (Tables 2 and 4 and Fig. 1 ), SW (e), SW (h), and SW (l) were the ideal primerprobe sets. In addition, the combination of SW (e) (HA targeted) and SW (h) (NA targeted) increased the detection rate to 59/60 ( 2 test; P ϭ 1.000), and the combination of SW (e) (HA targeted) and SW (l) (NA targeted) increased the detection rate to 60/60 ( 2 test; P ϭ 1.000) ( Table 5 ), indicating that a combination of primer-probe sets more effectively detects target viruses than individual primer-probe sets alone.
DISCUSSION
Although rRT-PCR assays are more sensitive than conventional reverse transcriptase PCR assays (21) and rapid antigenbased tests (12, 13) , each rRT-PCR assay may be different in sensitivity, specificity, and performance for the detection of pandemic influenza A/H1N1/2009 virus infection due to different design criteria and target genes. In this study, we evaluated 12 primer-probe sets developed by different groups for the detection of pandemic influenza A/H1N1 2009 virus. Our results demonstrated that although all primer-probe sets in this study had as high as 98.4 to 100% in silico coverage (Table 1) , some of the primer-probe sets have better specificity, sensitivity, and amplification efficiency than others.
Based on the results of the specificity analysis in this study, Hits were calculated using an in-house program described in Materials and Methods. the SW (j) (7) and SW (c) (31) sets are highly homologous to the HA genes of swine H1N2 (Fig. 1A) and to those of the human H1N1 strains (Fig. 1B and Table 2 ), respectively. The high identity between SW (j) and swine H1N2 is consistent with the notion that the pandemic influenza A/H1N1 2009 virus was a reassortant (swine H1N2 ϫ Eurasian swine H1N1) that obtained its HA gene from swine H1N2 (19) . We examined the cross-reactivities of primer-probe sets using a panel of virus strains and clinical specimens and found several primerprobe sets with high specificity [such as SW (a) (27) , SW (h) (24) , and SW (l) (32)]. However, considering the numerous HA and NA subtypes and the complicated evolutionary relationships between influenza A virus subtypes, the specificities of the primer-probe sets need to be further evaluated. As demonstrated in this report, it is often difficult to achieve both high sensitivity and high specificity for viral nucleic acid detection. The primer-probe sets SW (d) (32) , SW (e) (18), SW (g) (24) , and SW (i) (11) are highly sensitive (10 3 copies/ reaction) but react nonspecifically with other subtypes or viruses (Tables 2, 3 , and 5). Given this, the two NA gene-targeted sets, SW (h) and SW (l), and the HA gene-targeted set SW (e) appear to be the ideal primer-probe sets, because they had relatively high sensitivity [10 4 copies/reaction for SW (h) and SW (l) and 10 3 copies/reaction for SW (e)] and detection rates [56/60, P ϭ 0.134, for SW (h); 59/60, P ϭ 1.000, for SW (l); and 58/60, P ϭ 0.480, for SW (e)], as well as ideal specificity (Tables 2, 3, and 5) . Surprisingly, our results showed that the SW (f) (21) set had a relatively low sensitivity and detection rate (Tables 4 and 5 ) for pandemic influenza A/H1N1 2009 virus, although the optimized annealing temperature, 50°C, was selected from a series of temperatures. This may be attributed to the lower melting temperature (T m ) values of the primers and probe. The T m values of the forward primer, reverse primer, and probe of the SW (f) set were 47°C, 39°C, and 54°C, respectively, which are lower than the T m values recommended in the guidelines for designing primer-probe sets for quantitative assays (primers, 58 to 60°C; probes, 68 to 70°C) (http://www.uic.edu/depts/rrc/cgf/).
To keep the PCR parameters consistent with the original parameters and to derive accurate evaluation results, we did not change any parameters except the number of PCR cycles. Because the number of PCR cycles differed among the 12 assays compared in our study and the different numbers of rRT-PCR cycles may affect the comparisons of sensitivity and specificity, we set the number of PCR cycles to 45 in all assays. This number corresponds to the largest cycle number used in the 12 evaluated assays. The adjustment of cycle numbers did not affect the sensitivities and specificities of the primer-probe sets based on our comparisons (data not shown).
Compared with the U.S. CDC's rRT-PCR protocol for pandemic influenza A/H1N1 2009 virus, the SW (a), (b), (f), (j), and (k) primer-probe sets are less sensitive and less specific. Considering that there is no preferred standard method for evaluating rRT-PCR assays used to detect pandemic influenza A/H1N1 2009 virus, these assays should be further evaluated by a third-party referee in the future. Our preliminary conclusion may provide a basis for such future studies.
Due to limitations of primer-probe sets targeting a single gene and leading to false-negative diagnosis when sequence variations exist in the primer-and/or probe-targeting region, we evaluated two primer-probe sets to target the HA and NA genes simultaneously in order to increase the sensitivity of the rRT-PCR assay for detecting pandemic influenza A/H1N1 2009 virus. Our results show that from the standpoint of sensitivity and specificity, the cocktail of SW(e) (HA) and SW(h) (NA) or SW (e) (HA) and SW (l) (NA) is a recommended improvement over the single set of primers for the detection of 
